OPTIMIZED
THERAPEUTICS
Revolutionizing medication practice by a platform of localized,
controlled and prolonged drug release solutions.
LOCALLY PRESENTED
Revolutionizing medication practice by a platform of localized, controlled and prolonged drug release solutions.

POLYPID-sign

ABOUT US

We are a clinical-stage pharmaceutical company focused on developing, manufacturing and commercializing novel, locally administered therapies using our transformational PLEX (Polymer-Lipid Encapsulation matriX) technology. The Company’s product pipeline candidates are designed to address unmet medical needs by pairing PLEX technology with approved pharmaceuticals which are delivered locally at predetermined release rates and durations over periods ranging from days to several months. PLEX technology has the potential to improve patient outcomes and lower the overall cost of treatment by enabling customizable, controlled local delivery of drugs, thereby addressing many of the shortcomings of systemic administration and existing localized delivery systems. PLEX technology may represent a paradigm shift in the treatment of several localized medical conditions, including infection, pain, inflammation and cancer.

Read more >

TECHNOLOGY

The PLEX™ (Polymer-Lipid Encapsulation matriX) platform is a matrix made of alternating layers of polymers and lipids that entrap a therapeutic drug between them in order to form a protected reservoir that enables an effective localized drug delivery at the target site.

PLEX-based drug reservoirs enable prolonged delivery of unmodified drugs over periods ranging from days to several months. The application of our PLEX™ technology enables to optimize drug treatment regimens by predetermining release rates and durations, a rare combination of attributes.

The PLEX™ platform is able to accommodate a large variety of different molecules, regardless of size or physical characteristics:

VIDEO:
PLEX™ PLATFORM

Play

SMALL MOLECULES

PROTEINS

PEPTIDES

NUCLEIC ACIDS

Pipeline-img

PIPELINE

Our internal drug-based pipeline is focused on infection prevention and infection treatment and is based on our proprietary PLEX™ platform.

Our product candidates are designed to release antibiotics locally, over extended periods of time, in a variety of medical conditions.

PARTNERSHIP OPPORTUNITIES

We invite companies to partner with us by utilizing our PLEX™ platform as a local drug delivery vehicle that will optimize their drugs’ therapeutic effect and clinical outcome. We offer fast and easy partnering process:

 

In-vitro-evaluation In-vivo-evaluation Licensing-agreement

Read more >

PARTNERSHIP OPPORTUNITIES-img

Partner with us

We seek partners for the PLEX™ platform, which will provide companies a targeted, local drug delivery vehicle that will optimize their drugs’ therapeutic payload and clinical outcome.

Read More >

About

We are developing, manufacturing and eventually will be commercializing products based on our proprietary PLEX™ (Polymer-Lipid Encapsulation matriX) platform in the field of extended release, local drug delivery.

Read More >